Vaccines and Dementia: Unraveling Connections

This chapter explores the relationship between the Zostavax vaccine and its impact on shingles occurrence and dementia rates. The speakers analyze clinical trial and observational study data, discussing the vaccine's protective effects against dementia, emphasizing the role of healthcare changes and potential immunomodulatory effects. Additionally, they evaluate the transition to the Shingrix vaccine and its implications for future dementia research.